# International Leukemia Target Board

> **NCT05270096** · — · RECRUITING · sponsor: **Princess Maxima Center for Pediatric Oncology** · enrollment: 600 (estimated)

## Conditions studied

- Relapsed Hematologic Malignancy
- Refractory Hematologic Malignancy

## Interventions

- **OTHER:** Advice

## Key facts

- **NCT ID:** NCT05270096
- **Lead sponsor:** Princess Maxima Center for Pediatric Oncology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-12-31
- **Primary completion:** 2030-07-01
- **Final completion:** 2032-06-01
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2026-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05270096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05270096, "International Leukemia Target Board". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05270096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*